Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BRISTOL-MYERS-SQUIBB-COMP-11877/news/Bristol-Myers-Squibb-Compugen-Doses-First-Patient-in-Phase-1-2-Triple-Combination-Study-of-COM701-31259079/?utm_source=whatsapp&utm_medium=social&utm_campaign=share